MedPath

LORBRENA

LORBRENA

Approved
DIN Number

02485974

Drug Class

Human

Market Date

Apr 22, 2019

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02485974
AIG Number0161231002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01ED05 LORLATINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LORLATINIBActive
Strength: 100 MG
Monograph: LORLATINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.